Tetraethylene Glycol

Tetraethylene Glycol

SCHEMBL2219623

COS(=O)(=O)c1ccc(C)cc1.OCCOCCOCCOCCO

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.46
RECQL P46063 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GAA P10253 2/20 0.39
HPGD P15428 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
F2 P00734 1/20 0.38
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
PPARG P37231 1/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
MMP1 P03956 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triethylene Glycol SCHEMBL8163221 1.00 ALDH1A1 (0.46) ALDH1A1RECQLSMN1; SMN2GAAHPGD
Tetraethylene Glycol SCHEMBL11668304 0.94 ALDH1A1 (0.42) ALDH1A1RECQLSMN1; SMN2GAAHPGD
Triethylene Glycol SCHEMBL378725 0.94 ALDH1A1 (0.42) ALDH1A1RECQLSMN1; SMN2GAAHPGD
Ethylene Glycol SCHEMBL27552267 0.88 GAA (0.46) ALDH1A1RECQLSMN1; SMN2GAAKMT2A
Methoxymethane SCHEMBL1238785 0.87 ALDH1A1 (0.44) ALDH1A1RECQLSMN1; SMN2GAAHPGD
Methoxymethane SCHEMBL5555350 0.87 ALDH1A1 (0.44) ALDH1A1RECQLSMN1; SMN2GAAHPGD
SCHEMBL23417950 0.87 ALDH1A1 (0.46) ALDH1A1RECQLSMN1; SMN2GAAKMT2A
SCHEMBL916053 0.87 ALDH1A1 (0.46) ALDH1A1RECQLSMN1; SMN2GAAKMT2A
SCHEMBL7519771 0.87 ALDH1A1 (0.46) ALDH1A1RECQLSMN1; SMN2GAAKMT2A
SCHEMBL15416739 0.87 ALDH1A1 (0.46) ALDH1A1RECQLSMN1; SMN2GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1310533-B2 Ink composition containing a particular type of dye, and corresponding ink jet printing process AGFA GRAPHICS NV (BE) 2011-07-27 EP disclosed
EP-1486539-B1 Self-assembling dyes AGFA GRAPHICS NV (BE) 2009-08-26 EP disclosed
EP-1717283-B1 Ink composition containing a particular type of dye, and corresponding ink jet printing process. AGFA GRAPHICS NV (BE) 2008-07-16 EP disclosed
US-7355044-B2 Self-assembling dyes AGFA-GEVAERT N.V. (BE) 2008-04-08 US disclosed
EP-1310533-B1 Ink composition containing a particular type of dye, and corresponding ink jet printing process AGFA GEVAERT (BE) 2007-01-10 EP disclosed
EP-1717283-A1 Ink composition containing a particular type of dye, and corresponding ink jet printing process. Agfa-Gevaert (BE) 2006-11-02 EP disclosed
US-7025813-B2 Ink composition containing a particular type of dye, and corresponding ink-jet printing process AGFA-GEVAERT (BE) 2006-04-11 US disclosed
EP-1577356-A1 Ink composition containing a particular type of dye, and corresponding ink jet printing process. Agfa-Gevaert (BE) 2005-09-21 EP disclosed
US-20050051052-A1 Self-assembling dyes AGFA GRAPHICS NV (BE) 2005-03-10 US disclosed
EP-1486539-A2 Self-assembling dyes Agfa-Gevaert (BE) 2004-12-15 EP disclosed
US-20040206270-A1 Ink composition containing a particular type of dye, and corresponding ink-jet printing process AGFA GRAPHICS NV (BE) 2004-10-21 US disclosed
US-20030209166-A1 Ink composition containing a particular type of dye, and corresponding ink jet printing process AGFA-GEVAERT (BE) 2003-11-13 US disclosed
EP-1310533-A2 Ink composition containing a particular type of dye, and corresponding ink jet printing process Agfa-Gevaert (BE) 2003-05-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030209166-A1 Ink composition containing a particular type of dye, and corresponding ink jet printing process SNU13, SAMM50, SNX1 ALDH1A1 2702/4885RECQL 28/4885SMN1; SMN2 2293/4885
US-20050051052-A1 Self-assembling dyes CRY1, IK, RB1 ALDH1A1 233/4885RECQL 193/4885SMN1; SMN2 2087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.